Reviews

Health technology assessment processes for nanotechnologies: the ethical domain

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 15 April 2011
Accepted: 29 July 2011
Published: 12 August 2011
1783
Views
671
Downloads

Authors

The ethical assessment of the use of technologies is generally considered a component of the health technology assessment (HTA) processes. HTA is a multidisciplinary process that summarizes information about medical, economic, organizational, ethical, psychological, social and legal issues related to the implementation of a certain health technology in health care system and its main purpose is to inform policymaking. Unlike the other technologies nanotechnologies pose different risks and, therefore, new bioethical implications should be assessed. So, the ethical assessment of nanotechnologies within the HTA processes could be more problematic. The article intends to debate this complexity.

Downloads

Download data is not yet available.

Citations

Supporting Agencies

Antonio G. Spagnolo, Institute of Bioethics, A. Gemelli School of Medicine, Università Cattolica del Sacro Cuore, Rome
Full professor, Director, Institute of Bioethics

How to Cite



Health technology assessment processes for nanotechnologies: the ethical domain. (2011). Nanotechnology Development, 1(1), e1. https://doi.org/10.4081/nd.2011.e1